What's New?
The TESTING Study is an international study being conducted to clearly understand what benefits and risks are associated with corticosteroids in IgA nephropathy, using a corticosteroid called methylprednisolone. For more information visit our Surveys page.
Read about some of the many innovative Canadian kidney research projects funded by The Kidney Foundation in this new report.